Methylation is involved in the development of female breast cancer, with frequent methylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 in ductal carcinoma in situ and invasive ductal cancer [4]. Here, PAX5 is linked to breast carcinoma.